Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-20 Sale | 2024-05-22 7:23 pm | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 11,437 | $21 | $240,177 | 1,260,578 (Direct) | View |
| 2022-02-22 Sale | 2022-02-24 8:22 pm | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 84,515 | $19.56 | $1,653,113 | 1,220,036 (Direct) | View |
| 2021-05-11 Sale | 2021-05-13 8:32 pm | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 20,770 | $24.98 | $518,794 | 1,288,127 (Direct) | View |
| 2020-05-08 Sale | 2020-05-08 9:18 pm | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 45,000 | $25.84 | $1,162,800 | 1,052,568 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-30 Option Award | 2025-04-30 4:30 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 62,500 | $0 | 1,040,888 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:44 pm | N/A 2035-03-02 | Ovid Therapeutics Inc. | OVID | PAPADOPOULOS STELIOS Director | 90,000 | $0 | 90,000 (Direct) | View |
Ownership | 2025-03-04 4:42 pm | N/A N/A | Ovid Therapeutics Inc. | OVID | PAPADOPOULOS STELIOS Director | 0 | $0 | 200,000 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 8:21 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 18,838 | $0 | 1,279,416 (Direct) | View |
| 2024-05-20 Exercise | 2024-05-22 7:23 pm | 2017-05-25 2024-05-24 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 11,686 | $0 | 1,260,578 (Direct) | View |
| 2024-05-20 Exercise | 2024-05-22 7:23 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 11,686 | $19.57 | 1,260,578 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-21 4:23 pm | N/A 2034-05-19 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-17 4:38 pm | N/A 2034-05-15 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-15 4:19 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 250,000 | $1.6 | 978,388 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:28 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 4:50 pm | N/A 2033-06-12 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 9:13 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 20,718 | $0 | 1,260,329 (Direct) | View |
| 2023-04-13 Option Award | 2023-04-14 4:39 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 222,198 | $0.9001 | 728,388 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:13 pm | N/A N/A | BIOGEN INC. | BIIB | PAPADOPOULOS STELIOS Director | 2,255 | $0 | 38,301 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:18 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 9:19 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 19,575 | $0 | 1,239,611 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-01 4:12 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 2,222,222 | $0.36 | 5,061,929 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:27 pm | N/A N/A | BIOGEN INC. | BIIB | PAPADOPOULOS STELIOS Director | 1,275 | $0 | 36,046 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:43 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 8:26 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 16,424 | $0 | 1,304,551 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:32 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 40,000 | $6.3 | 1,288,127 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:32 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 40,000 | $3.38 | 1,288,127 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:32 pm | 2016-05-26 2023-05-25 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 120,000 | $0 | 1,288,127 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:32 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 40,000 | $3.13 | 1,288,127 (Direct) | View |
| 2020-12-04 Option Award(A) | 2021-01-27 8:16 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 793,528 | $0.6301 | 2,839,707 (Direct) | View |
| 2020-12-04 Option Award | 2020-12-07 4:21 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 595,146 | $0.125 | 2,581,875 (Direct) | View |
| 2020-12-04 Option Award | 2020-12-07 4:21 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 793,528 | $0.6301 | 2,581,875 (Direct) | View |
| 2020-11-24 Other | 2020-11-27 4:05 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | PAPADOPOULOS STELIOS Director 10% Owner | 255,094 | $0 | 2,875,000 (Indirect) | View |
Ownership | 2020-10-23 1:23 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | PAPADOPOULOS STELIOS Director 10% Owner | 0 | $0 | 2,875,000 (Indirect) | View |
| 2020-06-17 Option Award | 2020-06-19 4:40 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 23,250 | $0 | 23,250 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:20 pm | N/A N/A | BIOGEN INC. | BIIB | PAPADOPOULOS STELIOS Director | 1,470 | $0 | 34,771 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-22 9:05 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 15,538 | $0 | 1,188,897 (Direct) | View |
| 2020-05-13 Exercise | 2020-05-15 8:18 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 120,791 | $5.82 | 1,173,359 (Direct) | View |
| 2020-05-13 Exercise | 2020-05-15 8:18 pm | 2013-12-06 2020-12-05 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 120,791 | $0 | 1,173,359 (Direct) | View |
| 2020-05-08 Exercise | 2020-05-08 9:18 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 15,000 | $5.92 | 1,052,568 (Direct) | View |
| 2020-05-08 Exercise | 2020-05-08 9:18 pm | 2013-05-23 2020-05-22 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 45,000 | $0 | 1,052,568 (Direct) | View |
| 2020-05-08 Exercise | 2020-05-08 9:18 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 30,000 | $4.58 | 1,052,568 (Direct) | View |